We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$90.3B
AUM Growth
+$7.19B
Cap. Flow
+$4.56B
Cap. Flow %
5.05%
Top 10 Hldgs %
12.91%
Holding
4,527
New
567
Increased
2,145
Reduced
1,207
Closed
344

Sector Composition

Rank Sector Weight
1 Financials 11.61%
2 Technology 10.97%
3 Healthcare 10.51%
4 Consumer Discretionary 7.19%
5 Industrials 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYUT
3951
DELISTED
Synutra International, Inc.
SYUT
$58K ﹤0.01%
+15,194
New +$68.2K
TENX icon
3952
Tenax Therapeutics
TENX
$419M
$57K ﹤0.01%
1
FELP
3953
DELISTED
Foresight Energy LP
FELP
$57K ﹤0.01%
+36,257
New +$61.1K
BXE
3954
DELISTED
Bellatrix Exploration Ltd.
BXE
$56K ﹤0.01%
11,413
-4,817
-30% -$25.4K
CMLS
3955
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$54K ﹤0.01%
21,976
+19,333
+731% +$55.7K
NNA
3956
DELISTED
Navios Maritime Acquisition Corporation
NNA
$54K ﹤0.01%
2,318
-2,751
-54% -$72.4K
HLTH
3957
DELISTED
Nobilis Health Corp.
HLTH
$54K ﹤0.01%
24,493
+11,648
+91% +$37.8K
RLGT icon
3958
Radiant Logistics
RLGT
$411M
$53K ﹤0.01%
+17,954
New +$63.2K
PER
3959
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$52K ﹤0.01%
20,174
AST
3960
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$51K ﹤0.01%
+21,426
New +$77.5K
NAGE
3961
Niagen Bioscience
NAGE
$262M
$50K ﹤0.01%
+12,122
New +$57.3K
RKDA icon
3962
Arcadia Biosciences
RKDA
$1.37M
$49K ﹤0.01%
+24
New +$40.2K
SENS icon
3963
Senseonics Holdings Inc
SENS
$256M
$47K ﹤0.01%
+585
New +$41K
YGE
3964
DELISTED
Yingli Green Energy Holding Comp
YGE
$44K ﹤0.01%
10,867
BINI
3965
DELISTED
Bollinger Innovations
BINI
0
GEN
3966
DELISTED
Genesis Healthcare, Inc.
GEN
$43K ﹤0.01%
23,919
+9,100
+61% +$18.6K
CVRS
3967
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$43K ﹤0.01%
+30,347
New +$35.2K
BEBE
3968
DELISTED
Bebe Stores Inc
BEBE
$43K ﹤0.01%
+8,542
New +$41.2K
GIG
3969
DELISTED
GigPeak, Inc.
GIG
$42K ﹤0.01%
+21,671
New +$53.9K
ZVRA icon
3970
Zevra Therapeutics
ZVRA
$575M
$41K ﹤0.01%
647
-1,508
-70% -$248K
XBKS
3971
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
$41K ﹤0.01%
+2,267
New +$39.9K
TAT
3972
DELISTED
TransAtlantic Petroleum LTD.
TAT
$41K ﹤0.01%
+50,250
New +$43.8K
UONEK icon
3973
Urban One Class D
UONEK
$22.6M
$40K ﹤0.01%
+1,278
New +$29.7K
SYNC
3974
DELISTED
Synacor, Inc.
SYNC
$40K ﹤0.01%
+13,085
New +$32.9K
VSLR
3975
DELISTED
VIVINT SOLAR, INC.
VSLR
$39K ﹤0.01%
12,751
-94,990
-88% -$280K

Similar funds

Credit Suisse's Q2 2016 Portfolio in Review

As of Q2 2016, Credit Suisse held 4,527 positions worth $90.3B, up 8.7% from $83.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Credit Suisse deployed $4.56B of net new capital in Q2 2016, opening 567 new positions and adding to 2,145 existing holdings. Its largest new stake was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $305M trimmed.

  • Credit Suisse's largest Q2 2016 buy was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $526M increase.
  • Credit Suisse's biggest Q2 2016 reduction was Pfizer, cutting an estimated $305M.
  • Credit Suisse fully exited Airgas Inc in Q2 2016, selling an estimated $477M.
  • Credit Suisse's ten largest holdings make up 13% of its $90.3B portfolio in Q2 2016.
  • Credit Suisse opened 567 new positions and closed 344 in Q2 2016.
  • Credit Suisse's portfolio value rose 8.7% quarter-over-quarter to $90.3B.

Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.